Search icon

SCHENTAG CORP.

Company Details

Name: SCHENTAG CORP.
Jurisdiction: New York
Legal type: DOMESTIC BUSINESS CORPORATION
Status: Active
Date of registration: 03 Jan 1992 (33 years ago)
Entity Number: 1600293
ZIP code: 14226
County: Erie
Place of Formation: New York
Address: 100 CROSBY BLVD, EGGERTSVILLE, NY, United States, 14226
Principal Address: 100 CROSBY BOULEVARD, EGGERTSVILLE, NY, United States, 14226

Shares Details

Shares issued 200

Share Par Value 0

Type NO PAR VALUE

DOS Process Agent

Name Role Address
THE CORPORATION DOS Process Agent 100 CROSBY BLVD, EGGERTSVILLE, NY, United States, 14226

Chief Executive Officer

Name Role Address
JEROME J. SCHENTAG Chief Executive Officer 100 CROSBY BOULEVARD, EGGERTSVILLE, NY, United States, 14226

Form 5500 Series

Employer Identification Number (EIN):
161407479
Plan Year:
2012
Number Of Participants:
1
Sponsors Telephone Number:
Plan Year:
2011
Number Of Participants:
1
Sponsors Telephone Number:

History

Start date End date Type Value
2023-11-03 2023-11-03 Address 100 CROSBY BOULEVARD, EGGERTSVILLE, NY, 14226, USA (Type of address: Chief Executive Officer)
2023-11-03 2023-11-03 Shares Share type: NO PAR VALUE, Number of shares: 200, Par value: 0
1994-01-14 2023-11-03 Address 100 CROSBY BOULEVARD, EGGERTSVILLE, NY, 14226, USA (Type of address: Chief Executive Officer)
1993-03-11 1994-01-14 Address 100 CROSBY BLVD., EGGERTSVILLE, NY, 14226, USA (Type of address: Chief Executive Officer)
1993-03-11 1994-01-14 Address 100 CROSBY BLVD., EGGERTSVILLE, NY, 14226, USA (Type of address: Principal Executive Office)

Filings

Filing Number Date Filed Type Effective Date
231103002389 2023-11-03 BIENNIAL STATEMENT 2022-01-01
140305002470 2014-03-05 BIENNIAL STATEMENT 2014-01-01
120305002689 2012-03-05 BIENNIAL STATEMENT 2012-01-01
100322002200 2010-03-22 BIENNIAL STATEMENT 2010-01-01
080204002013 2008-02-04 BIENNIAL STATEMENT 2008-01-01

Trademarks Section

Serial Number:
76092106
Mark:
A TECHNOLOGY ASSESSMENT MODEL FOR ANTIBIOTIC REPLACEMENT
Status:
CANCELLED - SECTION 8
Mark Type:
TRADEMARK
Application Filing Date:
2000-07-20
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
A TECHNOLOGY ASSESSMENT MODEL FOR ANTIBIOTIC REPLACEMENT

Goods And Services

For:
MEDICAL AND PHARMACEUTICAL COMPUTER SOFTWARE FOR USE IN DATABASE MANAGEMENT
First Use:
2000-08-10
International Classes:
009 - Primary Class
Class Status:
Sec. 8 – Entire Registration
Serial Number:
76092105
Mark:
AIM ANTIBIOTIC IMPACT MODEL
Status:
CANCELLED - SECTION 8
Mark Type:
TRADEMARK
Application Filing Date:
2000-07-20
Mark Drawing Type:
Typeset: Word(s)/letter(s)/number(s)
Mark Literal Elements:
AIM ANTIBIOTIC IMPACT MODEL

Goods And Services

For:
MEDICAL AND PHARMACEUTICAL COMPUTER SOFTWARE FOR USE IN DATABASE MANAGEMENT
First Use:
2000-08-10
International Classes:
009 - Primary Class
Class Status:
Sec. 8 – Entire Registration

Date of last update: 15 Mar 2025

Sources: New York Secretary of State